Home Biosimilar Antibodies Others Others antibody Lampalizumab (Anti-Complement Factor D) For research use only.
Not for use in humans.

Lampalizumab (Anti-Complement Factor D)

Synonyms: RG 7417; TNX 234; Anti-CFD Recombinant Antibody

Lampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.

Lampalizumab (Anti-Complement Factor D)

Purity & Quality Control

≥99

Biological Activity

Description Lampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.

Product Details

CAS No. 1278466-20-8
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lampalizumab (Anti-Complement Factor D) | Lampalizumab (Anti-Complement Factor D) supplier | purchase Lampalizumab (Anti-Complement Factor D) | Lampalizumab (Anti-Complement Factor D) cost | Lampalizumab (Anti-Complement Factor D) manufacturer | order Lampalizumab (Anti-Complement Factor D) | Lampalizumab (Anti-Complement Factor D) distributor